Pharma

Your Article Summary

See Latest Articles

FDA Approves Samsca to Treat Hyponatremia
FDA Press Releases , 05/26/09

The U.S. Food and Drug Administration has approved Samsca tablets to treat hyponatremia, an abnormally low concentration of sodium in the blood. "With the approval of Samsca, physicians will have an additional tool to treat hyponatremia," said Norman Stockbridge, M.D., director of the Division of Cardiovascular and Renal Products in the FDA's Center for Drug Evaluation and Research.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/15/09

Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09

FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09

 See all of Drug/Product Approvals